UBS Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.7M | Sell |
60,385
-40,500
| -40% | -$22M | ﹤0.01% | 2185 |
|
|
2025
Q4 | $58.5M | Sell |
100,885
-36,525
| -27% | -$20.7M | 0.01% | 1462 |
|
|
2025
Q3 | $66.6M | Sell |
137,410
-109,396
| -44% | -$50.9M | 0.01% | 1362 |
|
|
2025
Q2 | $100M | Buy |
246,806
+139,102
| +129% | +$58.2M | 0.02% | 958 |
|
|
2025
Q1 | $53.6M | Buy |
107,704
+15,000
| +16% | +$8.12M | 0.01% | 1417 |
|
|
2024
Q4 | $48.2M | Sell |
92,704
-171,363
| -65% | -$94.2M | 0.01% | 1502 |
|
|
2024
Q3 | $163M | Buy |
264,067
+190,067
| +257% | +$113M | 0.04% | 493 |
|
|
2024
Q2 | $40.9M | Sell |
74,000
-17,000
| -19% | -$9.74M | 0.01% | 1170 |
|
|
2024
Q1 | $52.9M | Sell |
91,000
-33,568
| -27% | -$18.8M | 0.01% | 1007 |
|
|
2023
Q4 | $66.1M | Buy |
124,568
+74,068
| +147% | +$35.9M | 0.02% | 806 |
|
|
2023
Q3 | $25.6M | Buy |
50,500
+19,300
| +62% | +$10.3M | 0.01% | 1299 |
|
|
2023
Q2 | $16.3M | Buy |
31,200
+21,500
| +222% | +$11.6M | 0.01% | 1606 |
|
|
2023
Q1 | $5.59M | Sell |
9,700
-75,400
| -89% | -$42.5M | ﹤0.01% | 2406 |
|
|
2022
Q4 | $46.9M | Buy |
85,100
+62,760
| +281% | +$33.3M | 0.02% | 835 |
|
|
2022
Q3 | $11.3M | Buy |
+22,340
| New | +$12.5M | 0.01% | 1681 |
|
|
2022
Q2 | – | Sell |
-56,600
| Closed | -$33.4M | – | 10947 |
|
|
2022
Q1 | $33.4M | Sell |
56,600
-115,700
| -67% | -$66.5M | 0.01% | 1089 |
|
|
2021
Q4 | $115M | Buy |
172,300
+108,070
| +168% | +$67.5M | 0.03% | 544 |
|
|
2021
Q3 | $36.7M | Buy |
64,230
+59,800
| +1,350% | +$32.8M | 0.01% | 1053 |
|
|
2021
Q2 | $2.23M | Sell |
4,430
-8,000
| -64% | -$3.77M | ﹤0.01% | 3479 |
|
|
2021
Q1 | $5.67M | Sell |
12,430
-5,070
| -29% | -$2.42M | ﹤0.01% | 2464 |
|
|
2020
Q4 | $8.15M | Buy |
+17,500
| New | +$8.21M | ﹤0.01% | 2006 |
|
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$2.91M | – | 8408 |
|
|
2019
Q3 | $2.91M | Buy |
+10,000
| New | +$2.86M | ﹤0.01% | 2920 |
|
|
2019
Q2 | – | Sell |
-8,058
| Closed | -$2.21M | – | 8159 |
|
|
2019
Q1 | $2.21M | Buy |
+8,058
| New | +$2.01M | ﹤0.01% | 2911 |
|
|
2018
Q4 | – | Sell |
-50,600
| Closed | -$12.3M | – | 8289 |
|
|
2018
Q3 | $12.3M | Buy |
+50,600
| New | +$11.6M | ﹤0.01% | 1599 |
|
|
2017
Q3 | – | Sell |
-2,100
| Closed | -$366K | – | 7993 |
|
|
2017
Q2 | $366K | Sell |
2,100
-55,400
| -96% | -$9.31M | ﹤0.01% | 4347 |
|
|
2017
Q1 | $8.83M | Buy |
57,500
+46,600
| +428% | +$7.12M | ﹤0.01% | 1610 |
|
|
2016
Q4 | $1.54M | Buy |
+10,900
| New | +$1.61M | ﹤0.01% | 3155 |
|
|
2015
Q4 | – | Sell |
-22,100
| Closed | -$2.7M | – | 8576 |
|
|
2015
Q3 | $2.7M | Buy |
+22,100
| New | +$2.88M | ﹤0.01% | 2476 |
|
|
2015
Q2 | – | Sell |
-30,000
| Closed | -$4.03M | – | 8821 |
|
|
2015
Q1 | $4.03M | Buy |
30,000
+29,500
| +5,900% | +$3.8M | ﹤0.01% | 2256 |
|
|
2014
Q4 | $63K | Buy |
+500
| New | +$60.8K | ﹤0.01% | 6205 |
|
Other funds holding TMO
VCM
UBS Group's TMO Position: Q1 2026 in Review
UBS Group increased its Thermo Fisher Scientific (TMO) stake by 5.6% in Q1 2026, buying an estimated $70.6M and bringing the position to 2,453,453 shares worth $1.21B. The position accounts for 0.18% of the portfolio, ranked #104.
UBS Group first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.58B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- UBS Group held 2,453,453 shares of Thermo Fisher Scientific worth $1.21B as of Q1 2026.
- UBS Group bought 130,110 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.6M.
- Thermo Fisher Scientific made up 0.18% of UBS Group's portfolio in Q1 2026, its #104 holding.
- UBS Group first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Thermo Fisher Scientific position peaked at $1.58B in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.